CN1548025A - Lemaiwan pill and its prepn - Google Patents
Lemaiwan pill and its prepn Download PDFInfo
- Publication number
- CN1548025A CN1548025A CNA031244521A CN03124452A CN1548025A CN 1548025 A CN1548025 A CN 1548025A CN A031244521 A CNA031244521 A CN A031244521A CN 03124452 A CN03124452 A CN 03124452A CN 1548025 A CN1548025 A CN 1548025A
- Authority
- CN
- China
- Prior art keywords
- technology
- drying
- pill
- standby
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000006187 pill Substances 0.000 title claims abstract description 37
- 239000003814 drug Substances 0.000 claims abstract description 24
- 238000002360 preparation method Methods 0.000 claims abstract description 16
- 238000005516 engineering process Methods 0.000 claims description 47
- 239000000843 powder Substances 0.000 claims description 35
- 238000001035 drying Methods 0.000 claims description 31
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 30
- 239000000796 flavoring agent Substances 0.000 claims description 25
- 235000019634 flavors Nutrition 0.000 claims description 25
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 23
- 238000002156 mixing Methods 0.000 claims description 20
- 239000000463 material Substances 0.000 claims description 18
- 239000006071 cream Substances 0.000 claims description 17
- 239000012535 impurity Substances 0.000 claims description 12
- 239000007788 liquid Substances 0.000 claims description 12
- 239000012141 concentrate Substances 0.000 claims description 11
- 239000000341 volatile oil Substances 0.000 claims description 11
- -1 drying Substances 0.000 claims description 10
- 238000010025 steaming Methods 0.000 claims description 9
- 241000628997 Flos Species 0.000 claims description 8
- 238000010992 reflux Methods 0.000 claims description 8
- 229940079593 drug Drugs 0.000 claims description 7
- 238000000605 extraction Methods 0.000 claims description 7
- 229920000858 Cyclodextrin Polymers 0.000 claims description 6
- 238000009835 boiling Methods 0.000 claims description 6
- 239000000706 filtrate Substances 0.000 claims description 6
- 238000010438 heat treatment Methods 0.000 claims description 6
- 239000002904 solvent Substances 0.000 claims description 6
- 238000001694 spray drying Methods 0.000 claims description 6
- 238000001291 vacuum drying Methods 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 5
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 claims description 5
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims description 4
- 238000002481 ethanol extraction Methods 0.000 claims description 4
- 238000001914 filtration Methods 0.000 claims description 4
- 239000001863 hydroxypropyl cellulose Substances 0.000 claims description 4
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims description 4
- 238000000108 ultra-filtration Methods 0.000 claims description 4
- 239000002671 adjuvant Substances 0.000 claims description 3
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 2
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 claims description 2
- 229920003081 Povidone K 30 Polymers 0.000 claims description 2
- 229920002472 Starch Polymers 0.000 claims description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 2
- 229930006000 Sucrose Natural products 0.000 claims description 2
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical class [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- 238000004090 dissolution Methods 0.000 claims description 2
- 239000012530 fluid Substances 0.000 claims description 2
- 238000004108 freeze drying Methods 0.000 claims description 2
- 229910001385 heavy metal Inorganic materials 0.000 claims description 2
- 239000008101 lactose Substances 0.000 claims description 2
- YLGXILFCIXHCMC-JHGZEJCSSA-N methyl cellulose Chemical compound COC1C(OC)C(OC)C(COC)O[C@H]1O[C@H]1C(OC)C(OC)C(OC)OC1COC YLGXILFCIXHCMC-JHGZEJCSSA-N 0.000 claims description 2
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 2
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 2
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 2
- 239000002245 particle Substances 0.000 claims description 2
- 238000005325 percolation Methods 0.000 claims description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 2
- 239000001253 polyvinylpolypyrrolidone Substances 0.000 claims description 2
- 229920000523 polyvinylpolypyrrolidone Polymers 0.000 claims description 2
- 235000013809 polyvinylpolypyrrolidone Nutrition 0.000 claims description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 2
- 229910052708 sodium Inorganic materials 0.000 claims description 2
- 239000011734 sodium Substances 0.000 claims description 2
- 239000007921 spray Substances 0.000 claims description 2
- 239000008107 starch Substances 0.000 claims description 2
- 235000019698 starch Nutrition 0.000 claims description 2
- 210000002784 stomach Anatomy 0.000 claims description 2
- 239000005720 sucrose Substances 0.000 claims description 2
- 238000003809 water extraction Methods 0.000 claims description 2
- 239000008187 granular material Substances 0.000 abstract description 3
- 206010019233 Headaches Diseases 0.000 abstract 1
- 208000007536 Thrombosis Diseases 0.000 abstract 1
- 230000003213 activating effect Effects 0.000 abstract 1
- 230000017531 blood circulation Effects 0.000 abstract 1
- 208000029078 coronary artery disease Diseases 0.000 abstract 1
- 208000002173 dizziness Diseases 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 231100000869 headache Toxicity 0.000 abstract 1
- 230000007794 irritation Effects 0.000 abstract 1
- 238000012423 maintenance Methods 0.000 abstract 1
- 230000001737 promoting effect Effects 0.000 abstract 1
- 239000000047 product Substances 0.000 description 8
- 239000002552 dosage form Substances 0.000 description 7
- 239000011248 coating agent Substances 0.000 description 4
- 238000000576 coating method Methods 0.000 description 4
- 238000003556 assay Methods 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 239000001116 FEMA 4028 Substances 0.000 description 1
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 description 1
- 235000011175 beta-cyclodextrine Nutrition 0.000 description 1
- 229960004853 betadex Drugs 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
The present invention discloses Lemaiwan pill and its preparation process, and relates to the improvement in preparation form of available granule. The present invention has the advantages of improved maintenance in active components, fast medicine releasing speed, high bioavailability, less irritation, accurate dosage, etc. The medicine has the functions of activating vital energy, promoting blood circulation and dispersing blood clots; is used for headache, dizziness, coronary heart disease, etc. and has obvious curative effect.
Description
Technical field
This invention relates to the processing technology technical field of Chinese patent medicine pill, relates in particular to Lemaiwan pill and preparation method.
Background technology
Pill is a kind of conventional dosage forms, because quick development of modern science and technology, the pharmacy structural establishment is brought in constant renewal in and is regenerated, the extensive use of the appearance of novel pellet processing machine and new adjuvant, for this ancient dosage form of medicine pill has shone youthful vigor, advantages such as it has changed people to the traditional prejudice of traditional pill " black, big, thick ", and the pill that makes it to produce has that drug release rate is fast, bioavailability is high, zest is little, divided dose is accurate, takes, easy to carry; According to the relevant drug act of China, changing dosage form needs as a kind of new drug research, and the original dosage form of Lemaiwan pill is: LEMAI KELI, and listed in the Pharmacopoeia of People's Republic of China (2000 editions an one), the technology of former dosage form filters for seven flavors in the prescription decoct with water decocting liquid, concentrates, drying, granulation forms.This granule adopts extraction process by water, and volatility becomes easily loss, and some effective ingredient are difficult to propose.This granule supplementary product consumption is big, and its quality standard can further improve simultaneously.And this pharmaceutically dosage form is single, far can not satisfy people's medication demand.We use the modern pharmaceutical technology this product technology are done necessary improvement based on this, form new preparation, thereby and the quality of product is carried out overall monitor guarantee that product quality benefits the common people.This is significant to inheriting and develop motherland's medicine legacy.
Summary of the invention
The purpose of this invention is to provide a kind of Lemaiwan pill and preparation method, improve the quality of products, satisfy needs of medical treatment better.
The objective of the invention is such realization:
1. Lemaiwan pill and preparation method comprise the steps:
1.1 the prescription of Lemaiwan pill is formed:
Radix Salviae Miltiorrhizae 998-3493g Rhizoma Chuanxiong 499-1747g Radix Paeoniae Rubra 499-1747g Flos Carthami 499-1747g
Rhizoma Cyperi 249-875g Radix Aucklandiae 249-875g Fructus Crataegi 124-437g
Right amount of auxiliary materials is made 1000g altogether.
Its optimum formula is:
Radix Salviae Miltiorrhizae 1247-1996g Rhizoma Chuanxiong 623-998g Radix Paeoniae Rubra 623-998g Flos Carthami 623-998g
Rhizoma Cyperi 311-499g Radix Aucklandiae 311-499g Fructus Crataegi 156-250g
Right amount of auxiliary materials is made 1000g altogether.
1.2 Lemaiwan pill preparation technology
Technology one, seven flavor medicine is cleaned respectively, remove impurity, it is standby to be up to the standards; Get in the prescription seven flavors and be ground into coarse powder/be cut into decoction pieces, decoct with water 2-4 time, collecting decoction, filtration, filtrate is condensed into thick paste or concentrate drying is made dried cream powder, with appropriate amount of auxiliary materials mixing, pill, drying, promptly.
Technology two, seven flavor medicine is cleaned respectively, remove impurity, it is standby to be up to the standards; Get in the prescription seven flavors and be ground into coarse powder/be cut into decoction pieces, add water steaming and decocting 2-4 time, it is standby to collect volatile oil and water boiling liquid, volatile oil suitable cyclodextrin enclose or standby with an amount of anhydrous alcohol solution, water boiling liquid merges, filter, filtrate is condensed into thick paste/concentrate drying, and to make dried cream powder standby, above-mentioned thick paste/dried cream powder and cyclodextrin of volatile oil clathrate, and appropriate amount of auxiliary materials mixing, pill, drying, promptly.Or above-mentioned thick paste/dried cream powder and appropriate amount of auxiliary materials mixing, pill, drying, spray adds above-mentioned volatile oil solution, promptly.
Technology three, seven flavor medicine is cleaned respectively, remove impurity, it is standby to be up to the standards; Get in the prescription seven flavors and be ground into coarse powder/be cut into decoction pieces, with the ethanol extraction of 40-95%, extracting solution filters, and reclaims ethanol, is condensed into thick paste/concentrate drying and makes dried cream powder, with appropriate amount of auxiliary materials mixing, pill, drying, promptly.
Technology four, seven flavor medicine is cleaned respectively, remove impurity, it is standby to be up to the standards; Get in the prescription seven flavors and be ground into coarse powder/be cut into decoction pieces, with the ethanol extraction of 40-95%, extracting solution filters, and reclaims ethanol, and is standby; Medicinal residues decoct with water extraction, and decocting liquid filters, and merge with said extracted liquid, are condensed into thick paste/concentrate drying and make dried cream powder, with appropriate amount of auxiliary materials mixing, pill, drying, promptly.
1.3 by technology one, two, three, four prepared balls is Lemaiwan pill.
The technology Chinese crude drug is ground into coarse powder and was generally 5～40 order coarse powder, is preferably 10-20 order coarse powder.
The technology Chinese crude drug decocts with water/and the condition of steaming and decocting is decoction/steaming and decocting 2-4 time, amount of water is that 6-12 doubly measures for the first time, second and third time doubly measured for 4-8, each decocting time is 0.5-3 hour, technology one, two, three is preferably decoction/steaming and decocting 3 times, amount of water is 10 times of amounts for the first time, and second and third time is 8 times of amounts, each 1 hour.Technology four is preferably and decocts 2 times, and amount of water is 10 times of amounts for the first time, second, inferior be 8 times of amounts, each 1 hour.
The relative density of thick paste is 1.08～1.45 (60 ℃) in the technology, and optimal proportion is 1.30-1.35 (60 ℃).
The ball of gained can wrap film-coat in the technology, the film-coat material adopt stomach dissolution type film-coat pre-mixing agent (Opadry), hydroxypropyl cellulose, polyvinylpyrrolidone, hydroxypropyl emthylcellulose, polyvinyl alcohol, methylcellulose a kind of/multiple mixing uses.
Used adjuvant can be that one or more mixing such as sucrose, lactose, starch, beta-schardinger dextrin-, HP-, microcrystalline Cellulose, hydroxypropyl cellulose, carboxymethylstach sodium, Aspartane, polyvinylpolypyrrolidone, 30 POVIDONE K 30 BP/USP 30 are used in the technology.
The particle diameter of the ball of gained is 0.5-6mm in the technology, and optimum grain-diameter is 1.5-4mm.
In the technology ball of gained can directly use or the capsulae vacuus of packing in use.
Alcohol extraction process can adopt heating reflux method or percolation etc. for being solvent with the ethanol of 40-95% in the technology, and technology three is best for being solvent with 60-70% ethanol, heating and refluxing extraction 2 times, each 2 hours.Technology four is best for being solvent with 90-95% ethanol, heating and refluxing extraction 2 times, each 1 hour.
The ball drying can adopt vacuum drying, fluid bed drying, lyophilization etc. in the technology.
Filter in the technology and can adopt conventional the filtration, centrifugal, ultrafiltration, add filter behind the clarifier, centrifugal, add the method that filters ultrafiltration again behind the clarifier.
The drying of extract can adopt vacuum drying or adopt spray drying in the technology, and the vacuum drying temperature is controlled at 50-80 ℃, is preferably 60 ℃.The spray drying inlet temperature is 100-200 ℃, leaving air temp 50-150 ℃; Best relative density is 1.08-1.10 (60 ℃), and inlet temperature is 160-180 ℃, leaving air temp 80-100 ℃.
2. this product quality control mainly is discriminating, inspection, three aspects of assay.Former dosage form has the thin layer of Radix Salviae Miltiorrhizae, Rhizoma Chuanxiong, the Radix Aucklandiae to differentiate on differentiating, is now kept, and increases the thin layer discriminating of Flos Carthami, Radix Paeoniae Rubra; Must not cross 10/1000000ths to heavy metal on checking, arsenic salt must not be crossed 2/1000000ths limit examine; On assay, increased to Radix Salviae Miltiorrhizae quantitatively.
This invention its superiority compared with the prior art is: production technology more becomes fully rationally, quality standard improves greatly, makes product that the qualitative, quantitative control method of science be arranged, and makes the quality of product that guarantee arranged.
The specific embodiment
Embodiment 1: technology one, seven flavor medicine is cleaned respectively, remove impurity, it is standby to be up to the standards; Get in the prescription seven flavors and be ground into coarse powder, decoct with water 3 times, each 1 hour, collecting decoction filtered, and filtrate is concentrated into relative density 1.08-1.10, and spray drying is made dried cream powder, with appropriate amount of auxiliary materials mixing, pill, drying, coating, promptly.
Technology two, seven flavor medicine is cleaned respectively, remove impurity, it is standby to be up to the standards; Get in the prescription seven flavors and be ground into coarse powder, add the water steaming and decocting 3 times, each 1 hour, it is standby to collect volatile oil and water boiling liquid, and volatile oil is standby with being suitable for beta-cyclodextrin inclusion compound, and water boiling liquid merges, filter, filtrate is concentrated into relative density 1.08-1.10, and it is standby that spray drying is made dried cream powder, above-mentioned dried cream powder and cyclodextrin of volatile oil clathrate, and the appropriate amount of auxiliary materials mixing, pill, drying, coating, promptly.
Technology three, seven flavor medicine is cleaned respectively, remove impurity, it is standby to be up to the standards; Get in the prescription seven flavors and be ground into coarse powder, the alcohol reflux with 70% 2 times, each 2 hours, extracting solution filtered, recovery ethanol, concentrate drying is made dried cream powder, with appropriate amount of auxiliary materials mixing, pill, drying, coating, promptly.
Technology four, seven flavor medicine is cleaned respectively, remove impurity, it is standby to be up to the standards; Get in the prescription seven flavors and be ground into coarse powder, the alcohol reflux with 95% 2 times, each 1 hour, extracting solution filtered, and recovery ethanol is standby; Medicinal residues decoct with water and extract 2 times, and each 1 hour, decocting liquid filtered, and merge with said extracted liquid, and concentrate drying is made dried cream powder, with appropriate amount of auxiliary materials mixing, pill, drying, coating, promptly.
Claims (8)
1, a kind of Lemaiwan pill and preparation method is characterized in that:
(1) Radix Salviae Miltiorrhizae, Rhizoma Chuanxiong, Radix Paeoniae Rubra, Flos Carthami, Rhizoma Cyperi, the Radix Aucklandiae, Fructus Crataegi seven flavor medicine are cleaned respectively, remove impurity, it is standby to be up to the standards; Get in the prescription seven flavors and be ground into coarse powder/be cut into decoction pieces, decoct with water 2-4 time, collecting decoction, filtration, filtrate is condensed into thick paste/concentrate drying and makes dried cream powder, with appropriate amount of auxiliary materials mixing, pill, drying, promptly.
(2) Radix Salviae Miltiorrhizae, Rhizoma Chuanxiong, Radix Paeoniae Rubra, Flos Carthami, Rhizoma Cyperi, the Radix Aucklandiae, Fructus Crataegi seven flavor medicine are cleaned respectively, remove impurity, it is standby to be up to the standards; Get in the prescription seven flavors and be ground into coarse powder/be cut into decoction pieces, add water steaming and decocting 2-4 time, it is standby to collect volatile oil and water boiling liquid, volatile oil suitable cyclodextrin enclose/standby with an amount of anhydrous alcohol solution, water boiling liquid merges, filter, filtrate is condensed into thick paste/concentrate drying, and to make dried cream powder standby, thick paste/dried cream powder and cyclodextrin of volatile oil clathrate, and appropriate amount of auxiliary materials mixing, pill, drying, promptly; Or thick paste/dried cream powder and appropriate amount of auxiliary materials mixing, pill, drying, spray adds volatile oil solution, promptly.
(3) Radix Salviae Miltiorrhizae, Rhizoma Chuanxiong, Radix Paeoniae Rubra, Flos Carthami, Rhizoma Cyperi, the Radix Aucklandiae, Fructus Crataegi seven flavor medicine are cleaned respectively, remove impurity, it is standby to be up to the standards; Get in the prescription seven flavors and be ground into coarse powder/be cut into decoction pieces, with the ethanol extraction of 40-95%, extracting solution filters, and reclaims ethanol, is condensed into thick paste/concentrate drying and makes dried cream powder, with appropriate amount of auxiliary materials mixing, pill, drying, promptly.
(4) Radix Salviae Miltiorrhizae, Rhizoma Chuanxiong, Radix Paeoniae Rubra, Flos Carthami, Rhizoma Cyperi, the Radix Aucklandiae, Fructus Crataegi seven flavor medicine are cleaned respectively, remove impurity, it is standby to be up to the standards; Get in the prescription seven flavors and be ground into coarse powder/be cut into decoction pieces, with the ethanol extraction of 40-95%, extracting solution filters, and reclaims ethanol, and is standby; Medicinal residues decoct with water extraction, and decocting liquid filters, and merge with extracting solution, are condensed into thick paste/concentrate drying and make dried cream powder, with appropriate amount of auxiliary materials mixing, pill, drying, promptly.
2. Lemaiwan pill according to claim 1 and preparation method is characterized in that: the technology Chinese crude drug is ground into coarse powder and was generally 5～40 order coarse powder, and the best was a 10-20 order coarse powder; The technology Chinese crude drug decocts with water/and the condition of steaming and decocting is decoction/steaming and decocting 2-4 time, amount of water is that 6-12 doubly measures for the first time, and second and third time doubly measured for 4-8, and each decocting time is 0.5-3 hour, technology one, two, three the bests are decoction/steaming and decocting 3 times, amount of water is 10 times of amounts for the first time, and second and third time is 8 times of amounts, each 1 hour, technology four is preferably and decocts 2 times, for the first time amount of water is 10 times of amounts, second, inferior be 8 times of amounts, each 1 hour.
3. Lemaiwan pill according to claim 1 and preparation method is characterized in that: in the technology, the relative density of thick paste is 1.08～1.45 (60 ℃), and optimal proportion is 1.30-1.35 (60 ℃); Filter in the technology and can adopt conventional the filtration, centrifugal, ultrafiltration, add filter behind the clarifier, centrifugal, add the method that filters ultrafiltration again behind the clarifier.
4. Lemaiwan pill according to claim 1 and preparation method, it is characterized in that: the ball of gained can wrap film-coat in the technology, the film-coat material adopt stomach dissolution type film-coat pre-mixing agent (Opadry), hydroxypropyl cellulose, polyvinylpyrrolidone, hydroxypropyl emthylcellulose, polyvinyl alcohol, methylcellulose a kind of/multiple mixing uses; Used adjuvant can be sucrose, lactose, starch, beta-schardinger dextrin-, microcrystalline Cellulose, hydroxypropyl cellulose, carboxymethylstach sodium, Aspartane, polyvinylpolypyrrolidone, 30 1 kinds/multiple mixing use of 30 POVIDONE K 30 BP/USP in the technology.
5. Lemaiwan pill according to claim 1 and preparation method is characterized in that: the particle diameter of the ball of gained is 0.5-6mm in the technology, and optimum grain-diameter is 1.5-4mm; The ball drying can adopt vacuum drying, fluid bed drying, lyophilization in the technology; The ball of gained can directly use/pack in the capsulae vacuus and use in the technology.
6. Lemaiwan pill according to claim 1 and preparation method, it is characterized in that: alcohol extraction process is a solvent for the ethanol with 40-95% in the technology three, four, can adopt heating reflux method/percolation etc., technology three is best for being solvent with 60-70% ethanol, heating and refluxing extraction 2 times, each 2 hours, technology four was best for being solvent with 90-95% ethanol, heating and refluxing extraction 2 times, each 1 hour.
7. Lemaiwan pill according to claim 1 and preparation method, it is characterized in that: the drying of extract can adopt vacuum drying/employing spray drying in the technology, and the vacuum drying temperature is controlled at 50-80 ℃, and the best is 60 ℃, the spray drying inlet temperature is 100-200 ℃, leaving air temp 50-150 ℃; Best relative density is 1.08-1.10 (60 ℃), and inlet temperature is 160-180 ℃, leaving air temp 80-100 ℃.
8. Lemaiwan pill according to claim 1 and preparation method is characterized in that: the thin layer discriminating has been carried out to Flos Carthami, Radix Paeoniae Rubra in the quality standard aspect; Must not cross 10/1000000ths to heavy metal, arsenic salt must not be crossed 2/1000000ths limit examine; Radix Salviae Miltiorrhizae has been carried out quantitatively.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA031244521A CN1548025A (en) | 2003-05-24 | 2003-05-24 | Lemaiwan pill and its prepn |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA031244521A CN1548025A (en) | 2003-05-24 | 2003-05-24 | Lemaiwan pill and its prepn |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1548025A true CN1548025A (en) | 2004-11-24 |
Family
ID=34321707
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNA031244521A Pending CN1548025A (en) | 2003-05-24 | 2003-05-24 | Lemaiwan pill and its prepn |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1548025A (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102885889A (en) * | 2012-11-05 | 2013-01-23 | 太极集团重庆中药二厂有限公司 | Method for producing expelling extract |
| CN102895645A (en) * | 2012-11-05 | 2013-01-30 | 太极集团重庆中药二厂有限公司 | Method for preparing stomach pills of aucklandia and amomum fruit |
| CN102908601A (en) * | 2012-11-05 | 2013-02-06 | 太极集团重庆中药二厂有限公司 | Preparation method of huoxiang zhengqi pills |
| CN102908600A (en) * | 2012-11-05 | 2013-02-06 | 太极集团重庆中药二厂有限公司 | Preparation method for ease pills |
| CN111467429A (en) * | 2020-05-12 | 2020-07-31 | 徐文争 | Pulse-invigorating pill and preparation method thereof |
-
2003
- 2003-05-24 CN CNA031244521A patent/CN1548025A/en active Pending
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102885889A (en) * | 2012-11-05 | 2013-01-23 | 太极集团重庆中药二厂有限公司 | Method for producing expelling extract |
| CN102895645A (en) * | 2012-11-05 | 2013-01-30 | 太极集团重庆中药二厂有限公司 | Method for preparing stomach pills of aucklandia and amomum fruit |
| CN102908601A (en) * | 2012-11-05 | 2013-02-06 | 太极集团重庆中药二厂有限公司 | Preparation method of huoxiang zhengqi pills |
| CN102908600A (en) * | 2012-11-05 | 2013-02-06 | 太极集团重庆中药二厂有限公司 | Preparation method for ease pills |
| CN102908600B (en) * | 2012-11-05 | 2014-06-25 | 太极集团重庆中药二厂有限公司 | Preparation method for ease pills |
| CN102895645B (en) * | 2012-11-05 | 2014-06-25 | 太极集团重庆中药二厂有限公司 | Method for preparing stomach pills of aucklandia and amomum fruit |
| CN102908601B (en) * | 2012-11-05 | 2014-07-16 | 太极集团重庆中药二厂有限公司 | Preparation method of huoxiang zhengqi pills |
| CN102885889B (en) * | 2012-11-05 | 2014-07-30 | 太极集团重庆中药二厂有限公司 | Method for producing expelling extract |
| CN111467429A (en) * | 2020-05-12 | 2020-07-31 | 徐文争 | Pulse-invigorating pill and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1548104A (en) | Compound cordate bouttuynia bolus and its prepn | |
| CN1548025A (en) | Lemaiwan pill and its prepn | |
| CN1548096A (en) | Wenweishu bolus and its prepn | |
| CN1552364A (en) | Xuefu ecchymosis eliminating pills and their preparation | |
| CN1548120A (en) | Pain-relieving and abdominal mass-eliminatnig bolus and its prepn | |
| CN1548088A (en) | Liuwei'anxiaowan bolus and its prepn | |
| CN1548103A (en) | Fuyuekang bolus and its prepn | |
| CN1552379A (en) | Double red blood circulating pills and their preparation | |
| CN1552365A (en) | Migraine treating pills and their preparation | |
| CN1552371A (en) | Flower red pills and their preparation | |
| CN1552381A (en) | Antiphlogistic cholagogic pill and preparing method thereof | |
| CN1548117A (en) | Honeysuckle-skullcap root-forsythia and its prepn | |
| CN1552368A (en) | Fuyankang pills against gynecologic inflammation and their preparation | |
| CN1552374A (en) | Maren bowel nourishing micro-pills and their preparation | |
| CN1552384A (en) | Yilingjing pills and their preparation | |
| CN1548102A (en) | Menstruation regulating and spot eliminating bolus and its prepn | |
| CN1552372A (en) | Pills against gynecologic inflammation and their preparation | |
| CN1552367A (en) | Menstruation regulating and face nourishing pills and their preparation | |
| CN100496587C (en) | Pills for mammary gland disease and its preparation | |
| CN1548116A (en) | Breast nodule treating bolus and its prepn | |
| CN1548119A (en) | Yiqingwan bolus and its prepn | |
| CN1548100A (en) | Yangweishu bolus and its prepn | |
| CN1548110A (en) | Calculus-expelling Jinshi bolus and its prepn | |
| CN1548086A (en) | Spur treating bolus and its prepn | |
| CN1548107A (en) | Blood circulation promoting and pain relieving bolus and its prepn |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |